— Know what they know.
Not Investment Advice
Also trades as: ROG.SW (SIX) · $vol 444M · ROP.SW (SIX) · $vol 437M · RO.SW (SIX) · $vol 13M · RHHVF (OTC) · $vol 2M · 0QQ6.L (LSE) · $vol 2M · RHHBF (OTC) · $vol 0M · ROG.TO (TSX) · $vol 0M

RHHBY OTC

Roche Holding AG
1W: +2.1% 1M: +13.1% 3M: +9.8% YTD: +17.3% 1Y: +42.8% 3Y: +94.9% 5Y: +42.6%
$60.37
+0.39 (+0.65%)
 
Weekly Expected Move ±3.7%
$57 $59 $61 $63 $66
OTC · Healthcare · Drug Manufacturers - General · Tech Score Strong Buy · Power 70 · $384.8B mcap · 646M float · 0.290% daily turnover · Short 36% of daily vol
Credit Risk of going bust: lower than 83% of companies Debt: 9.0% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.46 (down 99.2%), Roche Holding AG would be worth roughly what it owes.
Total debt $38.25B against a stock market value of $384.81B.
Distance to default 10.59 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $23.09B (short-term plus half of long-term), stock volatility 28.7%; Altman Z'' 4.10. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

📊 Key Metrics

TTM
$61B
Revenue
+31.7% YoY
$12B
Net Income
+117.4% YoY
$15B
Free Cash Flow
+20.4% YoY
73.7%
Gross Margin
31.1%
Op. Margin
22.6%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE40.6%
ROA12.9%
ROIC24.9%

Valuation

P/E26.0
P/B9.9
EV/EBITDA0.0

Leverage

Debt/Equity0.97
Current Ratio1.23
Interest Cov.16.0x

Quality Scores

Piotroski F6/9
Altman Z—
Beneish M-2.31

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms